[Published] 2019/8/28 [Last updated] 2023/8/2
| Research | UMIN | PI |
|---|---|---|
| The study of investigating the genetic profiles of Exceptional Response in cancer therapies. | UMIN000016643 | Noboru Yamamoto |
| National Cancer Center Hospital (NCCH) Phase 1 Bank Study | UMIN000034212 | Takafumi Koyama |
| National Cancer Center Hospital (NCCH) Phase1 Liquid Study | UMIN000047567 | Takafumi Koyama |
| VOice-guided AI Cancer Evaluation (VOICE) Study | UMIN000049417 | Takafumi Koyama |
| The observational study of the practical application and clinical utility of cancer genomic profiling tests | UMIN000049415 | Takafumi Koyama |
| Retrospective Study of Safety and Efficacy in Phase I Oncology Trials | UMIN000042487 | Noboru Yamamoto |
| Study of high-precision method for circulating tumor cells with the aim of gene profiling test | UMIN000047566 | Takafumi Koyama |
| Research on model analyses derived from clinical specimens in early clinical trials | UMIN000049499 | Jun Sato |
| A study on immune-related adverse events in early phase clinical trials | UMIN000049431 | Yuki Katsuya |
| Gene profiling study for the patients with breast cancer | UMIN000021269 | Noboru Yamamoto |
| Prospective observational study on the impact of vaccination against COVID19 in patients with cancer | UMIN000049403 | Yuki Katsuya |
| Prospective observational study on the impact of vaccination against COVID19 in patients with cancer | UMIN000049403 | Yuki Katsuya |
| Prospective observational study on the impact of vaccination against COVID-19 in patients with hematopoietic tumors | UMIN000049407 | Yuki Katsuya |
| Prospective observational study on the impact of vaccination against COVID-19 in patients with hematopoietic tumors | UMIN000049407 | Yuki Katsuya |
| A feasible Study on the measurement of blood levels of anti-cancer drugs | UMIN000049429 | Yuki Katsuya |
| A Multicenter Observational Study of Whole Genome Analysis for patient benefit | UMIN000049428 | Yuki Katsuya |
| Prospective observational study on the impact of vaccination against COVID-19 among National Cancer Center staff. | UMIN000049430 | Yuki Katsuya |